Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
South Korean Finance Minister: Will closely monitor the market to curb volatility related to the stock market. Foreign investors’ portfolio adjustments are intensifying fluctuations in the Korean stock market. Will take action to address any herd effects in the financial markets. Rising leveraged stock investments are raising concerns.

South Korean Finance Minister: Will closely monitor the market to curb volatility related to the stock market. Foreign investors’ portfolio adjustments are intensifying fluctuations in the Korean stock market. Will take action to address any herd effects in the financial markets. Rising leveraged stock investments are raising concerns.

汇通财经汇通财经2026/06/04 00:20
Show original
South Korea's Finance Minister: Will closely monitor the market to curb volatility related to the stock market. Foreign investors adjusting their portfolios have intensified fluctuations in the South Korean stock market. Will take action to address any herd effect in the financial markets. The increase in leveraged equity investments is causing concern.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma

GlaxoSmithKline announced on Tuesday that it has reached an agreement with Chinese biotechnology company ImmuneOnco to acquire the global rights to one of the latter’s trispecific T-cell engagers (TCE) for a total transaction amount of up to $750 million.

智通财经2026/09/15 08:06
GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma